Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
315.59
-4.27 (-1.33%)
At close: Nov 6, 2025, 4:00 PM EST
316.16
+0.57 (0.18%)
After-hours: Nov 6, 2025, 7:59 PM EST
Amgen Employees
Amgen had 28,000 employees as of December 31, 2024. The number of employees increased by 1,300 or 4.87% compared to the previous year.
Employees
28,000
Change (1Y)
1,300
Growth (1Y)
4.87%
Revenue / Employee
$1,284,679
Profits / Employee
$250,179
Market Cap
169.94B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 28,000 | 1,300 | 4.87% |
| Dec 31, 2023 | 26,700 | 1,500 | 5.95% |
| Dec 31, 2022 | 25,200 | 1,000 | 4.13% |
| Dec 31, 2021 | 24,200 | -100 | -0.41% |
| Dec 31, 2020 | 24,300 | 900 | 3.85% |
| Dec 31, 2019 | 23,400 | 1,900 | 8.84% |
| Dec 31, 2018 | 21,500 | 700 | 3.37% |
| Dec 31, 2017 | 20,800 | 1,600 | 8.33% |
| Dec 31, 2016 | 19,200 | 1,300 | 7.26% |
| Dec 31, 2015 | 17,900 | 0 | - |
| Dec 31, 2014 | 17,900 | -2,100 | -10.50% |
| Dec 31, 2013 | 20,000 | 2,000 | 11.11% |
| Dec 31, 2012 | 18,000 | 200 | 1.12% |
| Dec 31, 2011 | 17,800 | 400 | 2.30% |
| Dec 31, 2010 | 17,400 | 200 | 1.16% |
| Dec 31, 2009 | 17,200 | 300 | 1.78% |
| Dec 31, 2008 | 16,900 | -600 | -3.43% |
| Dec 31, 2007 | 17,500 | -2,600 | -12.94% |
| Dec 31, 2006 | 20,100 | 3,600 | 21.82% |
| Dec 31, 2005 | 16,500 | 2,100 | 14.58% |
| Dec 31, 2004 | 14,400 | 1,500 | 11.63% |
| Dec 31, 2003 | 12,900 | 2,800 | 27.72% |
| Dec 31, 2002 | 10,100 | 2,400 | 31.17% |
| Dec 31, 2001 | 7,700 | 400 | 5.48% |
| Dec 31, 2000 | 7,300 | 900 | 14.06% |
| Dec 31, 1999 | 6,400 | 900 | 16.36% |
| Dec 31, 1998 | 5,500 | 192 | 3.62% |
| Dec 31, 1997 | 5,308 | 662 | 14.25% |
| Dec 31, 1996 | 4,646 | 600 | 14.83% |
| Dec 31, 1995 | 4,046 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AMGN News
- 12 hours ago - Stock Of The Day: Will Amgen Reverse Again? - Benzinga
- 1 day ago - Amgen: Q3 Earnings Indicate Strong Emphasis On R&D - Seeking Alpha
- 2 days ago - Amgen Inc. (AMGN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Amgen Raises Full-Year Outlook After Third-Quarter Profit, Sales Jump - WSJ
- 2 days ago - Amgen profit beats estimates, weight-loss data due by year-end - Reuters
- 2 days ago - AMGEN REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS - PRNewsWire
- 3 days ago - Biotech is back. Here's why these rallying stocks belong in your portfolio now. - Market Watch
- 6 days ago - AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND - PRNewsWire